IntegReview IRB provides daily meetings and reviews research in the United States, Latin America*, Japan and collaborates with a Canadian-based IRB to conduct Canadian site reviews.

IntegReview IRB has a collaboration with an Independent Biosafety Committee to provide IBC services for gene therapy research.

IntegReview IRB reviews the following types of research studies:

  • BioMedical
  • Medical Device
  • Biotech
  • Technology
  • Social-behavioral
  • Stem Cell
  • Educational
  • Evaluations
  • Consumer Preference
  • Observational / Registry
  • Investigator-initiated
  • Expanded Access
  • Emergency research
  • Exempt projects

Our clients include dedicated Sponsors, CROs, research clinics, institutions, hospitals, independent researchers, educators and evaluators.

*The following Latin American countries require local IRB/IEC review; therefore, IntegReview is unable to review research in Argentina, Brazil, Chile, Columbia, Mexico, Paraguay, Peru and Uruguay.

IntegReview IRB also provides the following services:

  • As-needed (emergency) meetings
  • Revision and maintenance of approved Informed Consent documents
  • Informed Consent development
  • Document translation
  • Pre-review and consultation, as requested
  • Competitive fees
  • Quality assurance/quality control
  • Flexibility to meet client specific needs
  • Electronic document management system (IRBManager)
  • IRB documents within 1-2 days of IRB review